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Purpose: Laparoscopic radical nephrectomy (LRN) is more challenging with increases 
in body mass index (BMI). Several recent studies have shown, however, that LRN can 
be safely performed even in obese patients. The influence of obesity on the perioperative 
outcomes of LRN has not been well elucidated for large renal tumors (＞7 cm), however. 
We estimated the impact of obesity on LRN for stage T1 and T2 renal cell carcinoma 
(RCC).
Materials and Methods: From January 2004 to March 2011, 266 patients underwent 
LRN (T1: 195, T2: 71). These patients were subdivided into the following two groups 
according to BMI: the nonobese group (BMI less than 25 kg/m
2) and the obese group 
(BMI greater than 25 kg/m
2). Perioperative outcomes were retrospectively compared 
between these two groups in T1 and T2 RCC patients. 
Results: There were no significant differences in perioperative outcomes between the 
obese and nonobese groups of T1 RCC patients. However, in T2 RCC patients, operative 
time and complication rate were significantly increased in the obese group.
Conclusions: Our results suggest that LRN can be safely performed in Korean patients 
with T1 RCC regardless of obesity. In T2 RCC patients, however, LRN may become more 
difficult with increasing BMI considering a longer operation time as well as a higher 
complication rate. We suggest that LRN for obese patients with T2 RCC be carefully 
considered.
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INTRODUCTION
Since 1991, when Clayman et al first reported laparoscopic 
nephrectomy [1], many investigations have shown the var-
ious advantages of the laparoscopic technique, such as de-
creased blood loss, rapid recovery, shorter hospital stay, 
less postoperative pain, and better cosmesis than with 
open nephrectomy [2,3]. Building on these gains, laparo-
scopic radical nephrectomy (LRN) is increasingly being 
performed at many centers and has become the standard 
technique for radical nephrectomies for T1 renal tumors (7 
cm or less), except in favorable cases of nephron-sparing 
surgery [4,5]. Recently, laparoscopic surgery has also tend-
ed to be performed for larger renal masses (＞7 cm) [6,7]. 
　The Korean National Health and Nutrition Surveys re-
ported an increase in the prevalence of obesity from 1995 
to 2001, and the prevalence of obesity was 31.8% in 2005 
[8]. As a result of this trend, laparoscopic surgery has been 
increasingly performed in obese patients. However, sev-
eral previous studies reported that obesity is a potential 
risk factor for poor outcomes after laparoscopic surgery. 
Therefore, obesity was regarded to be a relative contra-
indication to laparoscopy [9,10]. Despite these sugges-
tions, the use of laparoscopic surgery for surgical proce-
dures has been rapidly growing and most of the literature 
now agrees that the laparoscopic approach is feasible and 
safe in obese patients. 
　Several recent studies have concerned the effect of obe-Korean J Urol 2011;52:538-542
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TABLE 1. Comparison of patients’ demographic data and 
perioperative surgical outcomes in the T1 group
Non obese 
(n=135)
Obese 
(n=60)
p-value
Age (yr)
Sex (M/F)
BMI (kg/m
2)
Tumor size (cm)
Tumor laterality (Rt/Lt)
Operation time (min)
ABL (ml)
Transfusion rate (%)
Time to oral intake (days)
Hospital stay (days) 
Complication rate (%)
Open conversion (%)
57.7±11.6
87/48 
22.0±1.92
3.51±1.20
66/68
167.2±40.8
186.4±15.4
5/135 (3.7)
2.05±1.19
5.57±2.28
12/135 (8.9)
1 (0.7)
55.8±11.5 
42/18
27.0±1.84 
3.50±1.14
36/24
170.5±44.2
233.4±29.8
5/60 (8.3)
1.88±0.78
5.52±2.74
5/60 (8.3)
1 (1.6)
0.298
0.449
＜0.001
0.908
0.305
0.610
0.125
0.176
0.316
0.887
0.899
0.554
Data are presented as the mean±standard deviation. BMI: body 
mass index, ABL: actual blood loss 
sity on the perioperative outcomes of LRN [9-15]. However, 
most studies were limited to T1 renal cell carcinoma (RCC). 
In the present study, we estimated the impact of obesity on 
LRN in T2 RCC as well as T1 RCC.
MATERIALS AND METHODS
From January 2004 to March 2011, we retrospectively ana-
lyzed 266 patients who underwent LRN for T1 and T2 RCC. 
All LRN procedures were performed by a single experi-
enced laparoscopic surgeon. All patients were divided into 
T1 and T2 groups. These two groups were then subdivided 
into obese and nonobese groups according to body mass in-
dex (BMI) on the basis of the Asia-Pacific criteria in the 
World Health Organization classification. Patients with a 
BMI of 25 kg/m
2 or greater were defined as the obese group 
and those with a BMI of less than 25 kg/m
2 were defined 
as the nonobese group. Patients’ demographic parameters 
and perioperative surgical outcomes were compared be-
tween the obese and nonobese groups in the same stage 
group. The demographic parameters included age, BMI, 
gender, tumor size, and tumor laterality. To evaluate the 
operative outcomes, we compared operative time, actual 
blood loss (ABL) [16], transfusion rate, time to oral intake, 
hospital stay, and complication rate.
　LRN was performed by the transperitoneal approach in 
all cases. Pneumoperitoneum was achieved by using a 
Veress needle, and 3 or 4 ports were placed depending on 
the case. After laterocolic incision and mobilization of the 
colon, the renal hilum was dissected in the standard fash-
ion with adequate visualization of the renal vein and 
artery. We used 3 or 4, 10 or 15 mm Hem-o-Lok clips to con-
trol the renal artery. The renal vein was controlled by 3 or 
4, 15 mm clips. Para-aortic or paracaval and hilar lymph 
node dissection (LND) were performed when an enlarged 
lymph node was found radiologically before surgery or 
grossly during the operation. We removed the kidney, 
which was surrounded by the perinephric fat and envel-
oped by Gerota’s fascia, with or without a concomitant 
adrenalectomy. All of the specimens were removed intact 
without morcellation or fragmentation in an Endo Catch 
retrieval bag through a lower abdominal incision. An in-
dwelling Jackson-Pratt drain was placed in the retro-
peritoneal space through a 5 mm port site in all of the 
patients. 
　Continuous variables were compared with an in-
dependent Student’s t-test and categorical variables were 
assessed with the chi-square test. All p values were 2-sided, 
and p＜0.05 was considered significant. Analyses were 
conducted by using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, 
USA).
RESULTS
The non-obese T1 group and the obese T1 group included 
135 and 60 patients, and the non-obese T2 group and the 
obese T2 group included 49 and 22 patients, respectively. 
There were no significant differences in age, sex, mean tu-
mor size, or tumor laterality between the nonobese T1 and 
obese T1 groups or between the nonobese T2 and obese T2 
groups. 
　The mean operative time was similar between the non-
obese T1 and obese T1 groups (167.2 minutes vs. 170.5 mi-
nutes, p=0.610). Although blood loss and the transfusion 
rate were higher in the obese T1 group than in the non- 
obese T1 group, these differences were not significant 
(186.4 ml vs. 233.4 ml, p=0.125; 3.7% vs. 8.3%, p=0.176). 
Time to oral intake, hospital stay, and complication rate 
were also not significantly different between the obese T1 
and nonobese T1 groups (Table 1).
　The mean operative time was significantly different be-
tween the non-obese T2 and the obese T2 groups (200.7 mi-
nutes vs. 253.6 minutes, p＜0.001). Blood loss and the 
transfusion rate were also higher in the obese T2 group 
than in the non-obese T2 group (220.5 ml vs. 313.5 ml, 
p=0.193; 20.4% vs. 27.3%, p=0.522); however, these differ-
ences were not significant. The complication rate was sig-
nificantly higher in the obese T2 group than in the non- 
obese T2 group (10.2% vs. 31.8%, p=0.025). Time to oral in-
take and hospital stay were not significantly different be-
tween the obese T2 and the non-obese T2 groups (Table 2).
　In a total of 266 patients, 29 complications (10.9%) oc-
curred in our series. There was 1 case of open conversion 
in each group. Of 135 patients, 12 complications (8.9%; 1 
pulmonary edema, 2 ileus, 9 chylous ascites) occurred in 
the non-obese T1 group, and of 60 patients, 5 complications 
(8.3%; 1 wound dehiscence, 1 pneumonia, 3 chylous ascites) 
occurred in the obese T1 group (p=0.899). Of 49 patients, 
5 complications (10.2%; 1 ileus and 3 chylous ascites, 1 
pneumothorax) occurred in the nonobese T2 group, and of 
22 patients, 7 complications (31.8%, 1 pulmonary edema, 
1 wound dehiscence, 2 ileus, and 3 chylous ascites) occurred 
in the obese T2 group (p=0.025). According to the complica-
tion classification system suggested by Clavien et al [17], Korean J Urol 2011;52:538-542
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TABLE 2. Comparison of patients’ demographic data and 
perioperative surgical outcomes in the T2 group
Non obese 
(n=135)
Obese 
(n=60)
p-value
Age (yr)
Sex (M/F)
BMI (kg/m
2)
Tumor size (cm)
Tumor laterality (Rt/Lt)
Operation time (min)
ABL (ml)
Transfusion rate (%)
Time to oral intake (days)
Hospital stay (days) 
Complication rate (%)
Open conversion (%)
55.1±11.4
32/17
22.5±1.56
7.41±1.65
26/23 
200.7±52.0
220.5±41.1
10/49 (20.4)
2.14±0.98
6.29±2.97 
5/49 (10.2)
1 (2.0)
55.9±13.5
13/9
27.2±1.81
7.00±9.52
14/8
253.6±49.0
313.5±52.0
6/22 (27.3)
2.40±1.00 
6.27±2.85
7/22 (31.8)
1 (4.5)
0.790
0.615
＜0.001
0.287
0.406
＜0.001
0.193
0.522
0.297
0.986
0.025
0.555
Data are presented as the mean±standard deviation. BMI: body 
mass index, ABL: actual blood loss 
TABLE 3. Complications of obese and nonobese patients with T1 
or T2 renal cell carcinoma
T1 T2
Non obese Obese Non obese Obese
Pneumonia
Pulmonary edema
Ileus
Chylous ascites
Pneumothorax
Wound dehiscence
0
1
2
9
0
0
1
0
0
3
0
1
0
0
1
3
1
0
0
1
2
3
0
1
21 cases were grade I and 8 cases were grade II. There were 
no grade III or worse complications (Table 3).
DISCUSSION
Obesity is a major public health issue that affects more 
than 30% of Korean adults [8]. Many diseases, including 
diabetes, coronary artery disease, hypertension, breast 
cancer, colon cancer, and osteoarthritis, are associated 
with obesity [18]. Theoretically, obese patients with these 
comorbid conditions have an increased risk of poorer out-
comes after surgical treatment. At the beginning of laparo-
scopic surgery, obesity was considered to result in much 
technical challenge owing to the difficulty of trocar in-
sertion, inadequate insufflations, limited movement of the 
trocars, and a narrow working space [12]. Laparoscopic 
surgery in obese patients is also a challenge for anesthesiol-
ogists, and obesity may complicate respiratory and hemo-
dynamic management [19]. To minimize pulmonary com-
plications including atelectasis and pneumonia, preoxyge-
nation and rapid sequence induction should be performed 
and spirometry should be initiated in the immediate post-
operative period. We must carefully discuss with anes-
thesiologists the perioperative management of obese pa-
tients undergoing LRN. Therefore, in the mid 1990s, there 
was much controversy regarding whether the benefits of 
laparoscopy existed for obese patients. Mendoza et al re-
ported that obese patients were more prone to complica-
tions (57% vs. 16%) and Gill et al noted that obese patients 
underwent more conversions to open surgery (35% vs. 6%) 
[10,20]. However, in the current era, most of the literature 
now agrees that the laparoscopic approach is feasible and 
safe in obese patients. Futiga et al reported no statistically 
significant difference in operation time, blood loss, con-
version rate, complications, length of hospitalization, or 
time to ambulation in a study of 32 obese and 69 nor-
mal-weight patients undergoing LRN [12]. Doublet and 
Belair also found no significant difference in operative time 
or complications between obese and nonobese patients 
[21]. Miyake et al reported no significant differences in op-
erative time, estimated blood loss during LRN, and the in-
cidences of open conversion and postoperative complica-
tions between these two groups [22]. In an analysis of 26 
open radical nephrectomies and 30 LRNs, Lee et al re-
ported that LRN is effective for both obese and nonobese 
patients [15]. Moreover, several studies reported better 
outcomes of laparoscopic surgery in obese patients. Fazeli- 
Matin et al reported that laparoscopic renal and adrenal 
surgery in obese patients showed lower blood loss, quicker 
return of bowel function, less analgesic requirement, short-
er convalescence, and reduced hospital stay [11]. Klingler 
et al suggested that obese patients benefit more from lapa-
roscopy than do nonobese patients with respect to post-
operative pain and morbidity but do not experience more 
complications [23]. However, most of those reports were 
mainly intended for small-sized RCC, and there have been 
few studies about the impact of obesity for larger tumors. 
　With the development of laparoscopic technique, the in-
dications for LRN are expanding to encompass increas-
ingly larger tumors. However, large tumors often result in 
several problems for LRN, including decreased working 
space, difficulty with maintenance of operator orientation, 
incidence of significant parasitic vessels, and difficult 
specimen removal, and are often combined with enlarged 
lymph nodes. Therefore, large tumors entail technical con-
cerns even in the hands of experienced laparoscopic 
surgeons. Obesity also adds technical challenge to laparo-
scopic surgery. These challenges include inadequate insuf-
flation of the peritoneal cavity, difficulty of trocar in-
sertion, maintenance of pneumoperitoneum, and re-
strictive visualization due to limited exposure. Moreover, 
obese patients usually have a thicker abdominal wall that 
may result in limited movement of the trocars and de-
creased sensitivity felt by the surgeon. Obesity also induces 
more visceral fat, which has more parasitic vessels and con-
sequently has more potential for bleeding in the operation 
field with impairment of the visual field. On the other hand, 
laparoscopic surgery in obese patients has several poten-
tial advantages. Compared with open surgery, laparo-
scopic surgery can minimize skin incision, and this mini-
mal incision can prevent the risk of wound complications. Korean J Urol 2011;52:538-542
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In addition, laparoscopic surgery can reduce abdominal 
wall incision and closing time and may decrease the entire 
operative time. Reduction of operative time may reduce 
complications related to the patient’s general condition 
caused by prolonged anesthesia. 
　In our study, we found that obesity had no significant ef-
fect on operative outcomes if the tumor size was smaller 
than 7 cm. Blood loss, the transfusion rate, operation time, 
time to oral intake, hospital stay, and the complication rate 
were not significantly different. However, in cases of larger 
tumors (＞7 cm), we found that the operation time and com-
plication rate were significantly increased in the obese 
group. This may have been because of the narrower work-
ing space and increased visceral fat. In the case of small tu-
mors, although the working space may be decreased in 
obese patients, if we approach transperitoneally, enough 
working space can usually be secured. However, in the case 
of larger tumors, because of the volume effect of the tumor, 
more time can be taken for the dissection of the perirenal 
space as well as hilar dissection. Moreover, larger tumors 
may have a greater chance of being accompanied by en-
larged lymph nodes irrespective of lymph node invasion. 
Therefore, when we undertake LRN in T2 obese patients, 
the lymphatic channels can be easily injured during hilar, 
paraaortic, or paracaval dissection owing to the increased 
visceral fat tissue.
　For other consideration of our results, we suggest that 
the surgeon’s skill plays a major role in the perioperative 
outcomes of LRN in obese patients. The experienced lapa-
roscopic surgeon may overcome the difficulties of surgery 
in obese patients if the tumor size is small. However, the 
obese T2 RCC patients in our study showed a significant 
increase in operation times (200.7 vs. 253.6 minutes, re-
spectively, p＜0.001) and complication rates (10.2% vs. 
31.8%, p=0.025) compared with nonobese T2 RCC patients. 
In T2 RCC patients, who have larger tumors than T1 RCC 
patients, even experienced laparoscopic surgeons can be 
affected by obesity in the patient. Therefore, we suggest 
that obesity may be an important factor that negatively in-
fluences operative outcomes of LRN for T2 RCC patients. 
As a result, we should pay more attention if we are planning 
to perform LRN on T2 RCC in obese patients.
　The limitations of our study were that it had a retro-
spective design and did not involve comparisons with open 
surgery. We need to compare laparoscopic and open sur-
gery in obese T2 RCC patients. However, our data were 
enough to evaluate the surgical outcomes of LRN related 
to obesity, and the surgical techniques were standardized. 
Moreover, it is significant that this report is the first about 
the impact of obesity on LRN of large RCC in Korea.
CONCLUSIONS
Our results suggest that LRN can be safely performed in 
Korean patients with T1 RCC regardless of obesity. 
However, in T2 RCC patients, LRN may become more diffi-
cult with increasing BMI considering the longer operation 
time as well as the higher complication rate. In conclusion, 
we suggest that LRN in obese patients with T2 RCC must 
be considered carefully.
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